Achaogen (AKAO) Shows Strength: Stock Moves 13% Higher

Zacks

Achaogen, Inc. AKAO was a big mover last session, as its shares rose around 13% on the day. The stock price was driven by a series of favorable developments. This also led to far more shares changing hands than in a normal session. Yesterday’s rally breaks the recent trend for the company, as the stock is now up $2.70 to $3.28 in the past one-month time frame.

Over the last 30 days, the company witnessed one positive and three negative estimate revisions and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.

Achaogen currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked med-drugs stock is Juniper Pharmaceuticals, Inc. JNP, sporting a Zacks Rank #1 (Strong Buy).

Is AKAO going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research

Be the first to comment

Leave a Reply